It
is planned for the ISM and Gonzaga
University to engage in a partnership
focused on improved educational
opportunities and collaborative science.
Joint programs will allow undergraduate
science and computer science students to
pursue internship opportunities within
state-of-the-art laboratories working with
world-class scientists. Computer science
masters students may also be given an
opportunity to expand their exposure to
high-level applications in systems medicine
and genomics as well as high speed computing
and computational biology. Additionally, the
area of bio-medicine offers applications for
students pursuing a wide diversity of fields
including business administration and
ethics; both are areas in which students can
be a part of the cutting-edge in thought and
development. Programs of this nature will
not only improve the educational experience
for students but also allow them to
contribute to meaningful science at an early
stage in their career. It is also expected
that Gonzaga University and the ISM will
jointly recruit new faculty via joint
appointments focused in biology and
chemistry. Furthermore as a liberal arts
university with exceptional faculty,
Gonzaga, along
with the ISM, will also be able to offer
unique K-12 programs focused on inculcating
a new generation of scientists through
authentic learning experiences at the ISM.
As all of these programs mature, the ability
of these two institutions to recruit and
retain intellectual capital will grow
substantially while utilizing the efficiency
of shared resources.
The
benefits of partnerships between preeminent
state research universities, such as
Washington State University, and non-profit
research institutions are supported by a
wide-variety of precedence. The ability to
create joint research appointments and
programs, while sharing facilities, has a
number of significant advantages including
opportunities for increased funding and
recruitment. For example, leveraging
demonstrated expertise across both
institutions to submit joint funding
applications may increase the potential for
NIH credit and competitiveness for NIH
grants. The combination of tenured research
faculty and the private, focused,
translational approach to biomedical
research can be a powerful tool not only for
both institutions in building new
competitive programs but also for the growth
of the local community and the region.
Leveraging the two facilities and faculties,
in cooperation with local healthcare
organizations, will create a critical mass
for biomedical research-based economic
development. Not only will the core science
programs of WSU be involved, but there will
be significant opportunities for other
schools, such as the veterinary school and
the school of business. Additionally,
students at all levels will have access to
an interdisciplinary research institute with
leading edge instrumentation and research
cores while maintaining their connection to
the university. This will allow them to gain
unique experiences in a research institute
while creating placement opportunities for
post-doctoral students. In addition, the
ISM's clinical partnerships and clinical
cores may provide WWAMI medical students and
their faculty with clinical opportunities in
a pioneering area of medicine and the
opportunity to support first-in-man studies.
Partnership with the ISM may aid in
attracting research faculty for the
expanding Spokane WWAMI program.
The partnerships between the ISM and the
two primary healthcare systems in the Inland Northwest will focus on the
development of efficient clinical trial networks and joint research
activities. Through collaboration, these organizations will create a
world-class biomedical research and clinical environment that has
attractive affiliations with other leading research and clinical
institutions. One strategic goal will be to enhance the hospital’s
clinical research operations, with increased emphasis on early phase
clinical research and first-in-man studies especially in the area of
novel therapeutics. Such enhancement is expected to positively affect
patient draw, competitive position, and physician recruitment and
retention. In addition, both EHS and PHS are expected to serve as a
conduit for the clinical investigation of ISM discoveries. EHS, PHS, and
the ISM intend to leverage their networks and resources, as well as
evaluate opportunities, to collaborate in:
- High technology research facilities
and instrumentation
- NIH grant funding opportunities through joint programs
- Clinical patient base for application of discoveries and data
collection
- Patient databases and the opportunity to generate a medical
informatics function
- Clinical research facilities, administration, and researchers,
including their nationwide networks
The two healthcare systems will also have the ability to leverage the
unique access to a uniform patient information network to better target
potential patient populations and increase patient enrollment in potential
clinical trials; potentially resulting in increased clinical trails funding
and greater hospital bed utilization. Additionally, research appointments
for existing, interested physicians may help retain talent to the
institutions and region; strengthening the quality of regional physicians
and clinical practices overall, and therefore, the regional quality of
health care. Next, the parties intend to share access to laboratories and
clinics, educational resources, and research activities as appropriate and
available.
Based
upon the core competencies of each research institution, the ISB and the ISM
will pursue collaborative research programs, involving systems biology, as
well as offer joint appointments. For example, there will be the opportunity
to attract strong faculty and researchers to the area while sharing the cost
of recruitment and compensation. Additionally, joint appointments will help
to retain greater talent within the region, increasing the ability to
compete on a global scale. The cooperation between the two research entities
will also increase the size of each programs network and resources,
especially in regard to the development of patient applications.